Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2157-2163

  Masters, Gregory A ^a   Haraf, Daniel J ^a   Hoffman, Philip C ^a   Drinkard, Lee C ^a   Krauss, Stuart A ^a   Ferguson, Mark K ^a   Olak, Jemi ^a   Samuels, Brian L ^a   Golomb, Harvey M ^a   Vokes, Everett E ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0031779245     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2157     Document Type: Article

References (37)

1. Dillman RO, Herndon J, Seagren SL, et al: Improved survival in stage III non-small cell lung cancer: Seven year follow-up of Cancer and Leukemia Group B 8433 trial. J Natl Cancer Inst 88:1210-1215, 1996
2. Sause W, Scott C, Taylor S, et al: RTOG 8808/ECOG 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
3. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer. J Natl Cancer Inst 84:85-92, 1992
4. Schaake-Koning C, van den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326:524-530, 1992
5. Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992
6. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996
7. Wilke H, Fink U: Multimodality therapy for adenocarcinoma of the esophagus and esophagogastric junction. N Engl J Med 335:509-510, 1996
8. Ginsberg R, Vokes EE, Raben A. Non-small cell lung cancer, in DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer - Principles and Practice of Oncology (ed 5). Philadelphia, PA, Lippincott, 1997, pp 858-910
9. Rapp E, Pater JL, Willan A, et al: Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: Report of a Canadian multicenter randomized trial. J Clin Oncol 6:633-641, 1988
10. Woods RL, Williams CJ, Levi J, et al: A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 61:608-611, 1990
11. Quoix E, Dietermann A, Charbonneau J, et al: La chimiotherapie comportant du cisplatine est-elle utile dans le cancer bronchique non microcellulaire au stade IV? Resultants d'une etude randomisee. Bull Cancer 78:341-346, 1991
12. Cellerino R, Tummarello D, Guidi F, et al: A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 9:1453-1461, 1991
13. Kaasa S, Lund E, Thorud E, et al: Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer. Cancer 67:2443-2447, 1991
14. Cormier Y, Bergeron D, La Forge J, et al: Benefits of poly-chemotherapy in advanced non-small cell bronchogenic carcinoma. Cancer 50:845-849, 1982
15. Ganz PA, Figlin RH, Haskell CM, et al: Supportive care vs supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Cancer 63:1271-1278, 1989
16. Grilli R, Oxman AD, Julian JM: Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough? J Clin Oncol 11:1866-1872, 1993
17. Souquet PJ, Chauvin F, Boissel JP, et al: Polychemotherapy in advanced non-small cell lung cancer: A meta-analysis. Lancet 342:19-21, 1993
18. Marino P, Pampallona S, Preatoni A, et al: Chemotherapy versus supportive care in advanced non-small cell lung cancer: Results of a meta-analysis of the literature. Chest 106:861-865, 1994
19. Non-Small Cell Lung Cancer Collaborators Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311:899-909, 1995
20. Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicentre trial including 612 patients. J Clin Oncol 12:360-367, 1994
21. Wozniak AJ, Crowley JJ, Balcerzak SP, et al: Randomized phase III trial of cisplatin vs CDDP plus Navelbine in treatment of advanced non-small cell lung cancer: Report of a Southwest Oncology Group study (SWOG-9308). Proc Am Soc Clin Oncol 15:374, 1996 (abstr 1110)
22. Pritchard RS, Anthony SP: Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small cell lung cancer. Ann Intern Med 125:723-729, 1996
23. Vokes EE, Weichselbaum RR: Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934, 1990
24. Tannock IF: Treatment of cancer with radiation and drugs. J Clin Oncol 14:3156-3174, 1996
25. Masters GA, Vokes EE: Radiotherapy and concomitant chemotherapy, in Bertino J (ed): Encyclopedia of Cancer. San Diego, CA, Academic, 1997, pp 1471-1480
26. Trovo MG, Minatel E, Franchin G, et al: Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 24:11-15, 1992
27. Blanke C, Ansari R, Mantravadi R, et al: Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small cell lung cancer: A Hoosier Oncology Group protocol. J Clin Oncol 13:1425-1429, 1995
28. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13:1880-1892, 1995
29. Dewit L. Combined treatment of radiation and cis-diammine-dichloroplatinum II: A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13:403-426, 1987
30. Edelstein MP, Wolfe LA, Duch DS: Potentiation of radiotherapy by Navelbine® (NVB) in a human non-small cell lung cancer (NSCLC) line. Proc Am Assoc Cancer Res 36:611, 1995 (abstr 3637)
31. Masters GA, Hoffman PC, Hsieh A, et al: Phase I study of vinorelbine and ifosfamide in advanced non-small cell lung cancer. J Clin Oncol 15:884-892, 1997
32. Furese K, Fukuoka M, Takada Y, et al: A randomized phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer: A preliminary report. Proc Am Soc Clin Oncol 16:459, 1997 (abstr 1649)
33. Masters GA, Drinkard LC, Hoffman PC, et al: A phase I/phase II study of vinorelbine (Navelbine) with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am 1:288-294, 1995
34. Vokes EE, Leopold KA, Hemdon JE, et al: Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy in stage IIIB non-small cell lung cancer: Toxicity data (CALGB study 9431). Proc Am Soc Clin Oncol 16:455, 1997 (abstr 1636)
35. Roth JA, Fossella S, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86:673-689, 1994
36. Rosell R, Gomez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153-158, 1994
37. Masters GA, Vokes EE: Should non-small cell carcinoma of the lung be treated with chemotherapy? PRO: Chemotherapy is for non-small cell lung cancer. Am J Respir Crit Care Med 151:1285-1287, 1995